What is Eclipse Liquids?
Founded in 2013, Eclipse Liquids operates as a comprehensive manufacturing partner specializing in the development and production of premium CBD and eLiquid products. The company provides an end-to-end service model that encompasses custom recipe development, confidential private labeling, and large-scale manufacturing. By maintaining a versatile production environment, Eclipse Liquids effectively bridges the gap between small-scale entrepreneurial ventures and the high-volume requirements of global enterprises. Their market position is defined by a commitment to quality control and supply chain reliability, which are essential components in the highly regulated and rapidly evolving wellness and nicotine-alternative industries.
How much funding has Eclipse Liquids raised?
Eclipse Liquids has raised a total of $103K across 1 funding round:
Debt
$103K
Debt (2021): $103K with participation from PPP
Key Investors in Eclipse Liquids
PPP
Public-Private Partnership
What's next for Eclipse Liquids?
With the successful acquisition of $103K, Eclipse Liquids is strategically positioned to scale its manufacturing footprint and enhance its research and development capabilities. The firm is expected to prioritize the expansion of its production facilities to meet the rising demand for high-quality, compliant CBD and eLiquid solutions. Furthermore, the company will likely focus on deepening its integration within the supply chain, offering clients more robust logistical support and faster time-to-market for new product launches. As the regulatory landscape for these sectors continues to mature, Eclipse Liquids' focus on operational excellence and scalable infrastructure will be instrumental in maintaining its competitive advantage and driving long-term value for its stakeholders.
See full Eclipse Liquids company page
